Nabsys raises $21M for sequencing tech; Supreme Court to hear 'pay for delay' arguments;

 @FierceBiotech: Editor's corner: Will biotech grow in China and India without much VC help? More | Follow @FierceBiotech

@JohnCFierce: Weird deal. Receptos gets a PhII-ready AbbVie antibody. AbbVie has option to co-dev, co-promote. If it's worth anything, why farm it out? | Follow @JohnCFierce

@RyanMFierce: Takeda expanded a discovery alliance with Sripps Florida (pharma outsourcing more discovery work to academics.) Release | Follow @RyanMFierce

> Sequencing tech startup Nabsys has raised $21 million, with Bay City Capital leading the Series D. Story

> The big showdown between pharma companies and the FTC over "pay for delay" deals will soon be in the hands of the Supreme Court. Story

Pharma News

@FiercePharma: India's Lupin joins hunt for branded products to beef up a generics portfolio. Has $1B to spend. Report | Follow @FiercePharma

@EricPFierce: Bayer & Merck have weighed in on the big pay-for-delay case that the Supreme Court takes up this month. More | Follow @EricPFierce

> Bayer, Merck join fight against FTC in pay-for-delay case. More

> Merck hid Fosamax's links to femur fractures, lawyer says. More

Medical Device News

 @FierceMedDev: For GenMark, more flu was good news in 2012. More | Follow @FierceMedDev

 @MarkHFierce: France's EyeTechCare, with $13M in new funding, will pursue U.S. approval of its glaucoma ultrasound medical device. More | Follow @MarkHFierce

 @DamianFierce: Luminex is on board to handle companion diagnostics for Merck's blockbuster hopeful Alzheimer's drug. More | Follow @DamianFierce

> Analysts: Life Tech's suitors may balk at $15B price tag. More

> Zoll wins German patent battle over intravascular temperature management tech. More

Drug Delivery News

@MichaelGFierce: Vaginal nanogel with bee venom could prevent HIV infection. Story | Follow @MichaelGFierce

> Terumo evens with Abbott's Xience in drug-eluting stent study. News

> Study: Artificial pancreas improves overnight care in diabetic children. Article

> Shape-shifting proteins could aid drug delivery for cancer, infections. More

> Celgene drops $13M on Presage's 3-D drug delivery platform. Report

> PolyPid, MIS Implants partner for drug delivering dental bone-filler. Item

And Finally… A new survey finds that doctors often prescribe cholesterol-lowering drugs to patients who are unlikely to benefit from them. Story

Suggested Articles

Genentech followed a $1 billion pact with Sosei Heptares with discovery deals around cancer and neurological diseases with Skyhawk and Convelo.

The partners will use wearable devices to assess how heart failure patients function and feel after being discharged from hospitals.

After spinning out two companies at the start of the year, Sosei Heptares has now inked a new deal with Roche biologics unit Genentech.